Clinical Trial Update: Treatment of Epiretinal Membranes With Ranibizumab [NA]

View source ↗

Summary

A completed clinical trial evaluated ranibizumab for treatment of epiretinal membranes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epiretinal Membrane

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Queen's University | Conditions: Epiretinal Membrane | NA | Status: COMPLETED